License-Out
License Agreement Has Been Entered between iPS Academia Japan, Inc. and myriamed GmbH
iPS Academia Japan, Inc.: We executed a non-exclusive license agreement with myriamed GmbH, Germany which provides services in drug developm...
results 141 - 150 of 222
License-Out
License Agreement Has Been Entered with Bayer AG
We executed a non-exclusive license agreement for internal research with Bayer AG on the patents related to iPS cells technology which we ha...
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of November 2017 has been updated. Please see Patent Information for m...
Other
Our Office Closed Dec. 29 - Jan 3
Our office will be closed for winter holidays from Friday 29th December 2017 to Wednesday 3rd January 2018. Please understand that our earli...
License-Out
License Agreement Has Been Entered with Coyne Scientific, LLC
We executed a non-exclusive license agreement with Coyne Scientific, LLC which provides products and services related to iPS cells and iPS c...
License-In
Summary of 1 newly published patent application is added to "Patent Portfolio"
We released the summary of 1 newly published patent application from our "Patent Portfolio" as follows. AJ134 Therapeutic or prophylactic c...
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of October 2017 has been updated. Please see Patent Information for mo...
Event
BIO-Europe2017 in Germany
We presented our exhibition in BIO-Europe2017 in Berlin, Germany from November 6th (Mon.) till November 8th (Fri.), 2017. We very much appre...
Other
Updated the “Patent Information”
New patent information relates to iPS cell technologies for the month of September 2017 has been updated. Please see Patent Information for ...
Event
BioJapan2017 in Yokohama
We very much appreciate your visits to our booth at “BioJapan2017” in Yokohama from October 11th (Wed.) till October 13th (Fri.), 2017. The ...
